GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » EBITDA Margin %

Mountain Valley MD Holdings (FRA:20MP) EBITDA Margin % : -1,465.85% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mountain Valley MD Holdings's EBITDA for the three months ended in Dec. 2023 was €-0.60 Mil. Mountain Valley MD Holdings's Revenue for the three months ended in Dec. 2023 was €0.04 Mil. Therefore, Mountain Valley MD Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was -1,465.85%.


Mountain Valley MD Holdings EBITDA Margin % Historical Data

The historical data trend for Mountain Valley MD Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings EBITDA Margin % Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EBITDA Margin %
- - -8,435.44 -

Mountain Valley MD Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -1,465.85

Competitive Comparison of Mountain Valley MD Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's EBITDA Margin % falls into.



Mountain Valley MD Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Mountain Valley MD Holdings's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-3.485/0
= %

Mountain Valley MD Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.601/0.041
=-1,465.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings  (FRA:20MP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Mountain Valley MD Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Valley MD Holdings (FRA:20MP) Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings (FRA:20MP) Headlines

No Headlines